Innodata’s Rising Momentum: IBD Boost, 1605% Returns, & 2026 Growth Catalyst
Innodata’s strong market momentum, IBD rating lift, and 1,605% 3‑year return point to a promising 2026 growth catalyst as its biggest customer expands and small‑caps benefit from lower PE and Fed cuts.
3 minutes to read









